Yi-Feng Tian Selected Research

Cholangiocarcinoma

11/2023

A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM-STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Feng Tian Research Topics

Disease

7	Neoplasms (Cancer) 02/2024 - 12/2016
7	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 12/2016
3	Neoplasm Metastasis (Metastasis) 11/2023 - 12/2016
2	Adenocarcinoma 04/2022 - 01/2021
1	Fibrosis (Cirrhosis) 11/2023
1	Cholangiocarcinoma 11/2023
1	Sarcopenia 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Biliary Fistula 01/2018
1	Hepatitis 01/2018

Drug/Important Bio-Agent (IBA)

3	Long Noncoding RNAIBA 10/2022 - 09/2017
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2021
2	Circular RNAIBA 11/2023 - 04/2022
2	6-methyladenineIBA 10/2022 - 01/2021
2	N-methyladenosineIBA 10/2022 - 01/2021
2	Gemcitabine FDA Link 10/2022 - 04/2022
2	Cadherins (E-Cadherin)IBA 01/2021 - 12/2016
1	Small Interfering RNA (siRNA)IBA 11/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2023
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	olaparibIBA 04/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Muromonab-CD3 (Muromonab CD3)FDA Link 01/2022
1	MesothelinIBA 01/2022
1	AntigensIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	CyclinsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 12/2016

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 11/2023 - 04/2022
2	Therapeutics 06/2023 - 01/2022
2	Hepatectomy 01/2023 - 01/2018
1	Immunotherapy 06/2023
1	Length of Stay 01/2018